TEAM TASKED WITH GIVING US FIVE EXTRA YEARS OF HEALTH AND HAPPINESS
The National Innovation Centre for Ageing is based in The Catalyst, the stunning new building with a glass façade rearing like a horse’s head out of the 24-acre, £350m science park that is the...
Opening new pathways for bioprocessing
A pivotal link between industry and academia, Teesside University’s £22m National Horizons Centre (NHC) opened last September with two very clear objectives.
One is to drive research into bioprocessing, an often-overlooked subject through which life...
Nemera takes dermal treatments to millions of patients
Nemera is a world leader in design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generic industries, including complex dermal drug delivery devices.
Dermal pharmaceuticals, cosmetics and personal hygiene products all...
Access to Intellectual Property (IP) Rights in a Time of Emergency – Patent Pools...
Alex Bone, Patent Attorney, Partner, AA Thornton
The pharmaceutical and healthcare industry is often accused of misusing IP to extend exclusivity and delay reasonably priced access to life saving technologies. The recent pandemic has focussed attention...
Find out why County Durham’s NETPark is quickly becoming a global hub for bio-science...
Home to two UK catapult centres, three national innovation centres and one of the country’s leading AIM listed tech companies, The North East Technology Park (NETPark) really is a thriving hub of innovation making...
BIOQUELL HELPING PHARMACEUTICAL COMPANIES RESUME OPERATIONS POST-COVID-19
Bioquell Rapid Bio Decontamination Service (RBDS) enables businesses to quickly regain control of clean spaces and ramp up capacity
As the world prepares to enter the next phase of the COVID-19 pandemic with the potential...
JOHNS HOPKINS EXPERTS PUBLISH GUIDEBOOK FOR BLOOD PLASMA THERAPY
A team of Johns Hopkins experts has created a clinical guidebook to help hospitals and medical centers rapidly scale up their ability to deliver so-called convalescent plasma therapy, which leverages immune system components found...
Call to address lack of patient diversity in research
By Kate Shaw, CEO of Innovative Trials.
Innovative Trials, a clinical trial patient recruitment company, is calling on the medical research community and pharmaceutical sector to come together to tackle the issue of patient diversity in...
How a Novel Drug Discovery Technology Could Help in the Fight Against COVID-19
By Dr Asif Tulah, Alcyomics
Alcyomics has been adapting its service provision and assays to play their part in the race to find new treatments for COVID-19 (SARS-CoV-2) and to better understand how this virus works....
UCL supports worldwide dissemination of free-to-access manufacturing instructions for COVID-19 breathing aids
Governments across the world, healthcare providers and device manufacturers can now request a free of charge licence to the design and manufacturing files of a breathing aid developed by UCL, UCLH and Mercedes-AMG High...
IBM releases novel AI-powered technology to accelerate medical research for COVID-19
IBM has today released a new set of cloud- and AI-powered technologies to help researchers, doctors and scientists accelerate COVID-19 drug discovery.
These novel resources, from across IBM and available beginning today (Friday 3 April)...
UK offers accelerated patent protection for eco-friendly innovations
Using the Green Channel to accelerate a UK patent application.
AdamsonJones was able to obtain patent protection for client, LLEO Ltd, in just 15 months from the moment the Green Channel was used. This acceleration was crucial as...
Tackling the trillion dollar Alzheimer’s disease
It’s almost impossible to conceive the complexity that lies ahead in the challenge to address Alzheimer’s disease. But, picture standing in front of an old mansion house, completely overgrown with ivy, trees, and shrubs....
Build-up of brain proteins affects genes in Alzheimer’s disease
New research has shed fresh light on how the build-up of two proteins in the brain might affect the activity of genes involved in Alzheimer’s disease.
Researchers at the University of Exeter worked in collaboration...
Artificial intelligence yields new antibiotic
A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.
Using a machine-learning algorithm, MIT researchers have identified a powerful new antibiotic compound. In laboratory tests, the drug killed...
TABBY CAT OR TIGER?
Medics need to be fleet of foot when it comes to determining whether they are dealing with something tame or wild, but the traditional route to identifying bacteria takes time. Now a team of...